Cosmo announces FDA approval of GI Genius(TM) intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy

DUBLIN, April 12, 2021 -- (Healthcare Sales & Marketing Network) -- Cosmo Pharmaceuticals NV (SIX: COPN) today announced the FDA approval of GI Genius™ intelligent endoscopy system, its revolutionary device for lesion detection during colonoscopy. The ... Devices, Gastroenterology, FDA Cosmo Pharmaceuticals, Medtronic, GI Genius, intelligent endoscopy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news